Svas Biosana SpA
MIL:SVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Svas Biosana SpA
MIL:SVS
|
IT |
|
A
|
Akebia Therapeutics Inc
F:AX9
|
US |
|
I
|
IHS Markit Ltd
F:0M3
|
UK |
|
F
|
First Community Corp (South Carolina)
F:87Z
|
US |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
S
|
Sega Sammy Holdings Inc
XMUN:RYU
|
JP |
|
C
|
Cardinal Health Inc
F:CLH
|
US |
|
F
|
Fairfax Financial Holdings Ltd
XMUN:FFX
|
CA |
|
F
|
Fluor Corp
XMUN:FLU
|
US |
Intrinsic Value
The intrinsic value for Svas Biosana SpA (SVS) under the Base Case is hidden EUR. Compared with the current market price of 7.98 EUR, the stock appears hidden .
Do our valuations actually work? See backtest results .
SVS looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if SVS is one of them.
See where today’s valuation sits in SVS’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Svas Biosana SpA.
The intrinsic value for Svas Biosana SpA (SVS) under the Base Case is hidden EUR.
Compared with the current market price of 7.98 EUR, the stock appears hidden.
